141 related articles for article (PubMed ID: 1778760)
1. Renal pelvic carcinoma which shows metastatic potential to distant organs, induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice.
Murai T; Mori S; Hosono M; Takeuchi Y; Ohara T; Makino S; Takeda R; Hayashi Y; Fukushima S
Jpn J Cancer Res; 1991 Dec; 82(12):1371-7. PubMed ID: 1778760
[TBL] [Abstract][Full Text] [Related]
2. Effect of phenacetin pretreatment on renal pelvic carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice of both sexes.
Murai T; Mori S; Hosono M; Takeuchi Y; Oohara T; Makino S; Takeda R; Fukushima S
Teratog Carcinog Mutagen; 1994; 14(4):193-201. PubMed ID: 7992231
[TBL] [Abstract][Full Text] [Related]
3. Influences of aging and sex on renal pelvic carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice.
Murai T; Mori S; Hosono M; Takeuchi Y; Ohhara T; Makino S; Hayashi Y; Takeda R; Fukushima S
Cancer Lett; 1994 Jan; 76(2-3):147-53. PubMed ID: 8149343
[TBL] [Abstract][Full Text] [Related]
4. Induction of the renal pelvic and ureteral carcinomas by N-butyl-N-(4-hydroxybutyl)nitrosamine in SD/cShi rats with spontaneous hydronephrosis.
Mori S; Hosono M; Machino S; Nakai S; Makino S; Nakao H; Takeuchi Y; Takeda R; Murai T; Fukushima S
Toxicol Pathol; 1994; 22(4):373-80. PubMed ID: 7817126
[TBL] [Abstract][Full Text] [Related]
5. Lack of synergism in rat urinary tract carcinogenesis between prior uracil treatment and N-butyl-N-(4-hydroxybutyl)-nitrosamine administration.
Okumura M; Shirai T; Asamoto M; Ogiso T; Fukushima S
Cancer Lett; 1991 Jun; 58(1-2):81-5. PubMed ID: 2049787
[TBL] [Abstract][Full Text] [Related]
6. p53 and H-ras mutations and microsatellite instability in renal pelvic carcinomas of NON / Shi mice treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine: different genetic alteration from urinary bladder carcinoma.
Gen H; Yamamoto S; Morimura K; Min W; Mitsuhashi M; Murai T; Mori S; Hosono M; Oohara T; Makino S; Wanibuchi H; Fukushima S
Jpn J Cancer Res; 2001 Dec; 92(12):1278-83. PubMed ID: 11749692
[TBL] [Abstract][Full Text] [Related]
7. Promoting effect of monosodium aspartate, but not glycine, on renal pelvis and urinary bladder carcinogenesis in rat induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Kitamura M; Konishi N; Kitahori Y; Fukushima Y; Yoshioka N; Hiasa Y
Toxicol Pathol; 1996; 24(5):573-9. PubMed ID: 8923678
[TBL] [Abstract][Full Text] [Related]
8. LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
Morimura K; Yamamoto S; Murai T; Mori S; Chen TX; Wanibuchi H; Fukushima S
Carcinogenesis; 1999 Apr; 20(4):715-8. PubMed ID: 10223204
[TBL] [Abstract][Full Text] [Related]
9. Thymosin fraction 5 does not influence urinary tract carcinogenesis by phenacetin and N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice.
Murai T; Iwata H; Mori S; Hato F; Kimura S; Kinoshita Y; Wada S; Kishimoto T; Makino S; Oohara T
Oncol Res; 1995; 7(3-4):139-44. PubMed ID: 8555647
[TBL] [Abstract][Full Text] [Related]
10. Strain differences in N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis in rats.
Nakanowatari J; Fukushima S; Imaida K; Ito N; Nagase S
Jpn J Cancer Res; 1988 Apr; 79(4):453-9. PubMed ID: 3133335
[TBL] [Abstract][Full Text] [Related]
11. Lack of promotion of urinary bladder carcinogenesis by sodium bicarbonate and/or L-ascorbic acid in male ODS/Shi-od/od rats synthesizing alpha 2 mu-globulin but not L-ascorbic acid.
Mori S; Murai T; Hosono M; Machino S; Makino S; Chou C; Fukushima S
Food Chem Toxicol; 1997 Aug; 35(8):783-7. PubMed ID: 9350223
[TBL] [Abstract][Full Text] [Related]
12. No promotion of urinary bladder carcinogenesis by sodium L-ascorbate in male ODS/Shi-od/od rats lacking L-ascorbic acid-synthesizing ability.
Mori S; Murai T; Takeuchi Y; Hosono M; Ohhara T; Makino S; Hayashi Y; Shibata MA; Kurata Y; Hagiwara A
Carcinogenesis; 1991 Oct; 12(10):1869-73. PubMed ID: 1934267
[TBL] [Abstract][Full Text] [Related]
13. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation.
Hikosaka A; Ogawa K; Sugiura S; Asamoto M; Takeshita F; Sato SY; Nakanishi M; Kohri K; Shirai T
Int J Cancer; 2008 Mar; 122(6):1222-8. PubMed ID: 18027869
[TBL] [Abstract][Full Text] [Related]
15. Differences in susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis between SD/gShi rats with spontaneous hypospermatogenesis and SD/cShi rats with spontaneous hydronephrosis.
Murai T; Mori Y; Tatematsu K; Koide A; Hagiwara A; Makino S; Mori S; Wanibuchi H; Fukushima S
Cancer Sci; 2005 Oct; 96(10):637-44. PubMed ID: 16232194
[TBL] [Abstract][Full Text] [Related]
16. Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Yamamoto S; Masui T; Murai T; Mori S; Oohara T; Makino S; Fukushima S; Tatematsu M
Carcinogenesis; 1995 Oct; 16(10):2363-8. PubMed ID: 7586136
[TBL] [Abstract][Full Text] [Related]
17. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Hiasa Y; Kitahori Y; Konishi N; Shimoyama T; Miyashiro A
J Natl Cancer Inst; 1985 Jan; 74(1):235-9. PubMed ID: 3855482
[TBL] [Abstract][Full Text] [Related]
18. Uracil-induced calculi and carcinogenesis in the urinary bladder of rats treated simultaneously with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Okumura M; Shirai T; Tamano S; Ito M; Yamada S; Fukushima S
Carcinogenesis; 1991 Jan; 12(1):35-41. PubMed ID: 1988179
[TBL] [Abstract][Full Text] [Related]
19. The dynamics of the inflammatory response during BBN-induced bladder carcinogenesis in mice.
Degoricija M; Korac-Prlic J; Vilovic K; Ivanisevic T; Haupt B; Palada V; Petkovic M; Karaman I; Terzic J
J Transl Med; 2019 Nov; 17(1):394. PubMed ID: 31779626
[TBL] [Abstract][Full Text] [Related]
20. Possible inhibitory effects of promotion stage treatment with thymosin fraction 5 on N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated urinary tract carcinogenesis in NON/Shi mice.
Murai T; Mori S; Hato F; Kinoshita Y; Fukushima S
Int J Oncol; 1996 Jan; 8(1):117-24. PubMed ID: 21544339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
